Clinical Trial

Cohort of Prosthetic Joint Infections

Study acronym: COPINS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 29, 2022 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Management of prosthetic joint infections (PJI) is a challenging task. These infections include different clinical and microbiological settings calling upon various treatment strategies according to infection type (acute or chronic), bone quality, the involved micro-organism and the patient's general condition and willing. Treatment of PJI combines surgery and prolonged antibiotic therapy. In some patients with a high operative risk prolonged suppressive antibiotic therapy can be used. Lack of large prospective studies motivated the conception of this cohort with a long term follow up, regardless to PJI management procedures.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2016-06-10; most recent amendment 2022-03-28.
Trial Details
NCT Number NCT02801253
Lead Sponsor Groupe Hospitalier Diaconesses Croix Saint-Simon
Conditions Prosthetic Joint Infection
Enrollment 800 participants
Start Date 2015-09-11
Primary Completion 2025-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2022-03-29